14. Synthesis of 6-[18F]Fluorodopamine (6-[18F]FDA)

  1. Peter J. H. Scott and
  2. Brian G. Hockley
  1. Michael A. Channing,
  2. John L. Musachio and
  3. Jozef J. Kusmierz

Published Online: 4 JAN 2012

DOI: 10.1002/9781118140345.ch14

Radiochemical Syntheses: Radiopharmaceuticals for Positron Emission Tomography, Volume 1

Radiochemical Syntheses: Radiopharmaceuticals for Positron Emission Tomography, Volume 1

How to Cite

Channing, M. A., Musachio, J. L. and Kusmierz, J. J. (2012) Synthesis of 6-[18F]Fluorodopamine (6-[18F]FDA), in Radiochemical Syntheses: Radiopharmaceuticals for Positron Emission Tomography, Volume 1 (eds P. J. H. Scott and B. G. Hockley), John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/9781118140345.ch14

Editor Information

  1. Department of Radiology, University of Michigan School of Medicine, Ann Arbor, Michigan, USA

Author Information

  1. National Institutes of Health, PET Department, Clinical Center, Bethesda, Maryland, USA

Publication History

  1. Published Online: 4 JAN 2012
  2. Published Print: 13 JAN 2012

ISBN Information

Print ISBN: 9780470588956

Online ISBN: 9781118140345

SEARCH

Keywords:

  • synthesis of 6-[18F]fluorodopamine (6-[18F]FDA);
  • 6-[18F]FDA, functional imaging of sympathetic endocrine tumors;
  • fluorodestannylation

Summary

This chapter contains sections titled:

  • Introduction

  • Synthesis Procedures

  • Quality Control Procedures

  • Chemical Abstracts Nomenclature (Registry Number)

  • References and Notes